Why there is atrial fibrillation after cardiac operations?

Česká verzia

Authors: M. Jakubová ¹; Ľ. Družbacká ²; B. Stančák ²; P. Mitro ²; F. Sabol ³; A. Hermely ¹; P. Olexa ²; P. Török
Authors place of work: Klinika anestéziológie a intenzívnej medicíny VÚSCH, a. s., Košice, Slovenská republika, prednosta doc. MU Dr. Pavol Török, CSc. ¹; Klinika kardiológie VÚSCH, a. s., Košice, Slovenská republika, prednosta doc. MU Dr. Branislav Stančák, CSc. ²; Klinika srdcovej chirurgie VÚSCH, a. s., Košice, Slovenská republika, prednosta prim. MU Dr. František Sabol, PhD. ³
Published in the journal: Vnitř Lék 2011; 57(1): 92-96
Category: Reviews

Summary

Atrial fibrillation (AF) is the most frequent arrhythmias after cardiac operations. Its incidence ranges from 10– 65 %. Often there is a patient discomfort, prolongs hospitalization, increases costs of operation and may be permanent or recurrent course. The cause of postoperative AF is multifactorial. The prevention of non‑pharmacological and pharmacological interventions. The conventional treatment strategies include monitoring ventricular rate, restoration of sinus rhythm and prevention of thromboembolic events. The development of effective therapies designed to decrease the high incidence of postoperative AF may be important in the future.

Key words:
atrial fibrillation – cardiac surgery – symptoms – treatment

Zdroje

1. Villareal RP, Hariharan R, Liu BC et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43: 742– 748.

2. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061– 1073.

3. Aranki SF, Shaw DP, Adams DH et al. Predictors of atrial fibrillation after coronary artery surgery. Circulation 1996; 94: 390– 397.

4. Cox JL. Atrial fibrilation I: A new clasification system. J Thorac Cardiovasc Surg 2003; 126: 1686– 1692.

5. Fuster V, Ryden LE, Cannom DS et al. ACC/ AHA/ ESC guidelines for the management of patients with atrial fibrillation: full text. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writting Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Developed in collaboration with the European Heart Rhythm Association and Heart Rhythm Society. Circulation 2006; 114: 257– 354.

6. Echahidi N, Mohty D, Pibarot P et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007; 116: 213–219.

7. Bharucha DB, Kowey PR. Management and prevention of atrial fibrillation after cardiovascular surgery. The American Journal of Cardiology 2000; 85: 20– 24.

8. Echahidi N, Pibarot P, Oúhara G et al. Mechanism, prevention and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 739– 801.

9. Mathew JP, Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720– 1729.

10. Wijffels MC, Kirchhof CJ, Dorland R et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954– 1968.

11. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94: 2968– 2974.

12. Schotten U, Ausma J, Stellbrink C et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001; 103: 691– 698.

13. Mayr M, Yusuf S, Weir G et al. Combined Metabolomic and Proteomic Analysis of Human Atrial Fibrillation. J Am Coll Cardiol 2008; 51; 585– 594.

14. Allesie MA, Boyden PA, Camm AJ et al. Patophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769– 777.

15. Ak K, Akgun S, Tecimer T et al. Determination of histopatologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg 2005; 79: 1970– 1975.

16. Zacharias A, Schwann TA, Riordan CJ et al. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 2005; 112: 3247– 3255.

17. Wang TJ, Parise H, Levy D et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471– 2477.

18. Lonský V et al. Mimotělní oběh v klinické praxi. Praha: Grada Publishing 2004.

19. Bharucha DB, Kowey PR. Management and prevention of atrial fibrillation after cardiovascular surgery. The American Journal of Cardiology 2000; 85: 20– 24.

20. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: patophysiology and treatment: an update. Eur J Cardiothorac Surg 2002; 21: 232– 244.

21. Ishii Y, Schuessler RB, Sydney LG et al. Inflamation of atrium after cardiac surgery is associated with inhomogenity of atrial conduction and atrial fibrillation. J Surg Res 2006; 135: 68– 75.

22. Tselentakis EV, Woodford E, Chandz J et al. Inflamamtion effects on the electical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 2006; 13: 68– 75.

23. Lo B, Fijnheer R, Nierich AP et al. C- reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530– 1535.

24. Abdelhadi RA, Hitinder SG, Wagoner DR et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. The American Journal of Cardiology 2004; 93: 1176– 1178.

25. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C- reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542– 3548.

26. Archbold RA, Curzen NP et al. Off- pump coronary artery bypass graft surgery: the incidence of postoperative atrial fibrillation. Heart 2003; 89: 1134– 1137.

27. Becker KG, Cho- Chung YS, Kim MK Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 2003; 35: 336– 349.

28. Neuman RB, Bloom HL, Shukrullah I et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007; 53: 1652– 1657.

29. Shiroshita- Takeshita A, Brundel BJ, Burstein B et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 2007; 74: 75– 84.

30. Shiroshita- Takeshita A, Schram G, Lavoie J et al. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial- tachycardia remodeling in dogs. Circulation 2004; 110: 2313– 2319.

31. Mihm MJ, Yu F, Carnes CA et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001; 104: 174– 180.

32. Thijssen VL, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res 2001; 52: 14– 24.

33. Kim YM, Guzik TJ, Zhang YH et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005; 97: 629– 636.

34. Neuman RB, Bloom HL, Shukrullah I et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007; 53: 1652– 1657.

35. Connolly SJ, Cybulsky I, Lamy A et al. Double-blind, placebo- controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 2003; 145: 226– 232.

36. Crystal E, Connolly SJ, Sleik K et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002; 106: 75– 80.

37. Mitchell LB, Exner DV, Wyse DG et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early after Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA 2005; 294: 3093– 3100.

38. Patel AA, White CM, Gillespie EL et al. Safety of amiodarone in the prevention of post-operative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm 2006; 63: 829– 837.

39. Crystal E, Connolly SJ, Sleik K et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002; 106: 75– 80.

40. Dunning J, Treasure T, Versteegh M et al. On behalf of the EACTS Audit and Guidelines Commettee: Guidelines on prevention an management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg 2006; 30: 852– 872.

41. Patti G, Chello M, Candura D et al. Randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA- 3 study. Circulation 2006; 114: 1456– 1461.

42. Marin F, Pascual DA, Roldan V et al. Statins and post-operative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006; 97: 55– 60.

43. Šetina M, Pospíšilová H et al. Význam nesteroidních antirevmatik v prevenci pooperační fibrilace síní v kardiochirurgii. Cor Vasa 2002; 44: 396– 400.

44. Halonen J, Halonen P, Jarvinen O et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007; 297: 1562– 1567.

45. Prakash A, Delfaut P, Krol RB et al. Regional right and left atrial activation patterns during single-and dual- site atrial pacing in patients with atrial fibrillation after heart surgery: a metaanalysis. J Cardiovasc Electrophysiol 2003; 14: 127– 132.

46. Kmec J. Praktické aspekty elektrickej kardioverzie u pacientov s perzistujúcou fibriláciou predsiení. Kardiol prax 2007; 5: 163– 174.

47. Bucerius J, Gummert JF, Birger MA et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003; 75: 472– 478.

48. Meurin P, Weber H, Renaud N et al. Evolution of the post-operative pericardial effusion after day 15. Chest 2004; 125: 2182– 2187.

49. Epstein AE, Alexander JC, Gutterman DD et al. Anticoagulation: American College of Chest Physicians guidelines for the prevention and management of post-operative atrial fibrillation after cardiac surgery. Chest 2005; 128: 24S– 27S.

50. Stančák B. Odhad rizika tromboembolizmu pri fibrilácii predsiení – nevyhnutný predpoklad správneho výberu antikoagulačnej stratégie. Praktická a preventívna kardiológia : príloha časopisu Bedeker zdravia 2010; Suppl 1 (2010): 45–48.

51. Gage BF, Waterman AD et al. Validation of clinical classification schemes for predictive stroke: result from the National Registry of atrial fibrillation. JAMA 2001; 285: 2864–2870.